Healthcare Services

Mammalian Cell Fermentation Technology Market Forecast Showing Industry Trends and Progress

April 23, 2026April 26, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Mammalian Cell Fermentation Technology Market Expected To Reach Based On Its 2026 Value?

The mammalian cell fermentation technology market size has experienced significant rapid growth recently. It is projected to increase from $57.37 billion in 2025 to $64.07 billion by 2026, achieving a compound annual growth rate (CAGR) of 11.7%. The expansion observed in the historic period is attributable to the growth of monoclonal antibody therapeutics, early success of mammalian cell expression systems, increasing biopharmaceutical approvals, reliance on batch-based fermentation processes, and the expansion of academic research in cell culture technologies.

The mammalian cell fermentation technology market size is anticipated to experience substantial growth over the coming years. It is projected to expand to $94.89 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.3%. This expansion during the forecast period can be attributed to several factors, including the increasing demand for biologics and biosimilars, enhanced investment in cell line engineering, the advancement of personalized medicine, expanding vaccine development pipelines, and rising biomanufacturing capacity in emerging markets. Significant trends for the forecast period involve a growing adoption of CHO cell-based production platforms, an increasing need for high-yield and scalable bioprocessing, greater outsourcing to CDMOs for biologic manufacturing, the expansion of single-use and modular bioreactor systems, and a heightened focus on process optimization and yield consistency.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16473&type=smp

Which Key Drivers Are Affecting The Mammalian Cell Fermentation Technology Market Development?

The escalating demand for biologics is projected to drive the growth of the mammalian cell fermentation technology market moving forward. Biologics are medical products derived from living organisms or their components, frequently utilized in treating conditions such as cancer, autoimmune disorders, and infectious diseases. The increasing need for biologics is propelled by advances in biotechnology, their proven effectiveness in managing common chronic diseases like cancer and autoimmune disorders, regulatory authorizations, and increased investment in research and development. Mammalian cell fermentation technology efficiently produces complex biologics, thereby fulfilling the rising demand for personalized and targeted therapeutics. Its scalability, versatility, and capability to yield high-quality proteins foster innovation within the biopharmaceutical industry. For instance, in February 2024, according to the National Library of Medicine, a US-based medical library, in 2023, the Food and Drug Administration (FDA) approved 55 new drugs, which included 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), marking a 50% increase compared to the 37 approvals in 2022. Therefore, the expanding demand for biologics is stimulating the growth of the bacterial cell fermentation technology market.

How Is The Mammalian Cell Fermentation Technology Market Segmented Across Different Segment Categories?

The mammalian cell fermentation technology market covered in this report is segmented –

1) By Type: Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation, Other Types

2) By Application: Monoclonal Antibodies, Recombinant Proteins, Vaccines, Hormones, Enzymes, Other Applications

3) By End-Use: Biopharmaceutical Companies, Contract Research Organizations And Contract Development and Manufacturing Organizations, Academic And Research Institutes

Subsegments:

1) By Chinese Hamster Ovary (CHO) Cell Fermentation: Suspension CHO Cell Lines, Serum-Free CHO Fermentation, High-Yield Recombinant Protein Production

2) By Human Embryonic Kidney (HEK) Cell Fermentation: Transient Transfection-Based Fermentation, Viral Vector Production Systems, Serum-Free HEK Cell Cultures

3) By Baby Hamster Kidney (BHK) Cell Fermentation: Vaccine Antigen Production, Stable Cell Line Fermentation, Suspension BHK Cell Cultures

4) By Murine Myeloma Cell Fermentation: Monoclonal Antibody Production, Hybridoma-Based Fermentation, Serum-Free Antibody Expression Systems

5) By Other Types: Insect Cell Line Fermentation, Stem Cell–Derived Mammalian Cells, Custom Engineered Cell Line Fermentation

What Trends Are Transforming The Mammalian Cell Fermentation Technology Market?

Leading companies in the mammalian cell fermentation technology market are prioritizing the development of innovative technologies, such as mammalian cell culture, to enhance their market standing. Mammalian cell culture is a vital tool across various domains, including biomanufacturing, research, and regenerative medicine, facilitating the creation of therapeutic proteins, vaccines, and functional cells or tissue analogs. For example, in June 2024, Syntegon, a Germany-based biotechnology company, introduced its new Modular Bioprocessing Platform (MBP) at Achema 2024, specifically engineered to address key hurdles in biopharmaceutical production. This cutting-edge platform delivers an extremely flexible, fully integrated, and automated solution appropriate for a wide range of applications, including microbial and mammalian cell cultures, proteins, peptides, oligonucleotides, plasmid DNA, and recombinant vaccines. The MBP’s modular construction enables faster lead times and lower costs while preserving high functionality and quality, in accordance with the “made in Germany” standard. Its prefabricated cleanroom layout positions all supporting technology outside the cleanroom, thereby improving efficiency and simplifying upkeep.

Which Organizations Play A Role In The Mammalian Cell Fermentation Technology Market Landscape?

Major companies operating in the mammalian cell fermentation technology market are AbbVie Inc., Thermo Fisher Scientific Inc, AstraZeneca PLC, Roche Holdings Inc., Merck KGaA, AGC Group, Lonza Group Ltd., Boehringer Ingelheim GmbH, Catalent Inc., Sartorius AG, Samsung Biologics Co. Ltd., WuXi Biologics, Biocon Limited, Eppendorf AG, KBI Biopharma Inc., Fujifilm Diosynth Biotechnologies, Avid Bioservices Inc., BiOZEEN, Nordmark Pharma GmbH, Scorpius BioManufacturing Inc

Get The Full Mammalian Cell Fermentation Technology Market Report:

https://www.thebusinessresearchcompany.com/report/mammalian-cell-fermentation-technology-global-market-report

Which Region Is The Leading Market For The Mammalian Cell Fermentation Technology Market?

North America was the largest region in the mammalian cell fermentation technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mammalian cell fermentation technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Mammalian Cell Fermentation Technology Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/mammalian-cell-fermentation-technology-global-market-report

Browse Through More Reports Similar to the Global Mammalian Cell Fermentation Technology Market 2026, By The Business Research Company

Primary Cell Culture Market Report 2026

https://www.thebusinessresearchcompany.com/report/primary-cell-culture-global-market-report

Cell Culture Media Market Report

https://www.thebusinessresearchcompany.com/report/cell-culture-media-global-market-report

Cell Cultures Market Report

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795